News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio



4/28/2010 11:07:08 AM

LELYSTAD and 'S-HERTOGENBOSCH, The Netherlands, April 28, 2010 /PRNewswire/ -- Pepscan, the Netherlands based biotechnology firm focusing on protein mimicking technology for the generation of immune therapeutics, today announced that it reached a partnering agreement for its therapeutic vaccine portfolio with Immunovo BV of 's-Hertogenbosch. Under the terms of the agreement Pepscan will receive an undisclosed cash payment as well as a minority interest in Immunovo.

Read at PR Newswire


comments powered by Disqus
Pepscan
 
 
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES